Editorial

Gastroesophageal Reflux Disease and Obesity

Authors: James V. Lewis MD

Abstract

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

References1. Storr M, Meining A, Allescher HD. Pathophysiology and pharmacological treatment of gastroesophageal reflux disease. Dig Dis 2000;18:93–102.StorrM]]MeiningA]]AllescherHDPathophysiology and pharmacological treatment of gastroesophageal reflux disease.Dig Dis20001893-1022. Hazan TB, Gamarra FN, Stawick L, et al. Nissen fundoplication and gastrointestinal-related complications: a guide for the primary care physician. South Med J 2009;102;1041–1045.HazanTB]]GamarraFN]]StawickL&etal;Nissen fundoplication and gastrointestinal-related complications: a guide for the primary care physician.South Med J20091021041-10453. Herbella FA, Sweet MP, Tedesco P, et al. Gastroesophageal reflux disease and obesity. Pathophysiology and implications for treatment. Gastrointest Surg 2007;11:286–290.HerbellaFA]]SweetMP]]TedescoP&etal;Gastroesophageal reflux disease and obesity. Pathophysiology and implications for treatment.Gastrointest Surg200711286-2904. Ayazi S, Hagen JA, Chan LS, et al. Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg 2009;13:1440–1447.AyaziS]]HagenJA]]ChanLS&etal;Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms.J Gastrointest Surg2009131440-14475. Wu JC, Mui LM, Cheung CM, et al. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology 2007;132:883–889.WuJC]]MuiLM]]CheungCM&etal;Obesity is associated with increased transient lower esophageal sphincter relaxation.Gastroenterology2007132883-8896. Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc 2001;15:986–989.PerezAR]]MoncureAC]]RattnerDWObesity adversely affects the outcome of antireflux operations.Surg Endosc200115986-9897. Kendrick ML, Houghton SG. Gastroesophageal reflux disease in obese patients: the role of obesity in management. Dis Esophagus 2006;19:57–63.KendrickML]]HoughtonSGGastroesophageal reflux disease in obese patients: the role of obesity in management.Dis Esophagus20061957-638. Ikramuddin S. Surgical management of gastroesophageal reflux disease in obesity. Dig Dis Sci 2008;53:2318–2329.IkramuddinSSurgical management of gastroesophageal reflux disease in obesity.Dig Dis Sci2008532318-2329